Just a reminder that we will be having the
OpenHIE Architecture call Monday, August 28 at 10:00 a.m. EDT.
Agenda
IHE conformance testing
a.
Goal: Start thinking about what testing you propose and the resources needed
DevOPS - Should we continue to have a DevOPS call? If so, what is the scope and how do we move forward?
a.
Goal: get input
AOB
Please remember * to review and comment on the
Architecture Diagram slides* between now and 9/28 so we can discuss on 10/8 call (Derek and Ryan had specific items they wanted to add).
<img border=“0” width=“483” height=“136” id="_x0000_i1026" src="/uploads/default/original/1X/3749f9d01b34eb6a82d51db6bbc551c9aeda1aba.png" alt="We will be using Zoom:
Join from PC, Mac, Linux, iOS or Android: https://iu.zoom.us/j/832179402
Or Telephone: Dial: +1 646 558 8656 (US Toll) or +1 669 900 6833 (US Toll)
Meeting ID: 832 179 402
International numbers available: https://zoom.us/u/c1Vz5ASHm
">
Thanks!
**Michelle Cox ** |****Program Coordinator, Global Health Informatics
1101 West Tenth Street
Indianapolis, IN 46202
Tel 317-274-9324 | Fax 317-274-9305
Skype ID: miclcox | Facebook.com/regenstriefinstitute |
www.regenstrief.org
My normal work hours are Monday – Friday, 7:30 a.m. – 4:00 p.m. Eastern Time
Confidentiality Notice: The contents of this message and any files transmitted with it may contain confidential and/or privileged information and are intended solely for the use of the named addressee(s).
Additionally, the information contained herein may have been disclosed to you from medical records with confidentiality protected by federal and state laws. Federal regulations and State laws prohibit you from making further disclosure of such information
without the specific written consent of the person to whom the information pertains or as otherwise permitted by such regulations. A general authorization for the release of medical or other information is not sufficient for this purpose.
If you have received this message in error, please notify the sender by return e-mail and delete the original message. Any retention, disclosure, copying, distribution or use of this information
by anyone other than the intended recipient is strictly prohibited.